[SeekAndFind]

Limitations

The study was limited to 28 days, as in August 2020 the prevention scheme changed to a monthly dose of ivermectin 0.4 mg/kg. There was no RT-PCR test at the start or exit of this study, neither in the ivermectin group nor in the control group. There is the possibility that asymptomatic cases were not detected. Additionally, selection of groups was based on adherence.

Conclusions

Pre-exposure prophylaxis (PrEP) for COVID-19 with a weekly oral dose of ivermectin 0.2 mg/kg was statistically significant in exposed healthcare personnel at the CMBO and CMPC after 28 days of follow up, with only 1.8% of the physicians and health collaborators developing SARS-CoV-2 infection versus 6.6% in the control group (p-value = 0.006). Ivermectin reduced the risk of contagion with COVID-19 by 74% compared to the control group (HR 0.26, 95% CI [0.10, 0.71]). These results suggest that compassionate use of weekly ivermectin could be an option as a preventive method in healthcare workers and as an adjunct to immunizations, while further well-designed randomized controlled trials are developed to facilitate scientific consensus.

[zeestephen]

74% is very impressive.

On the other hand, the study was done in the Dominican Republic.

I want to trust these numbers, but there are a lot of startling medical studies that come out of poor developing countries that create a one time PR sensation, and then disappear forever.

[inchworm]

Everyone knows this but our hospitals, liberals, and our CDC

[meyer]

Reduced the risk by 74% - I’d say that in the long term, that’s superior to the non-existent reduction given by the Jab.